|
Post by sf1981 on Nov 10, 2015 8:35:14 GMT -5
Ok, folks. This is what it comes down to and it's not like we should fein surprise at where the company is today. Anyone following our story and doing reasonable due diligence should know that the company needs to raise capital. It's not rocket science. The news has been out there for at least two financial quarters. It's time to man up now. Blame is for losers. Winners work harder. It's easy to complain when times are difficult. I'm adding to my position. I like the odds. I like the potential return on this $2+ stock. We have another year, for sure. And, after that, who knows. But that's what you get in life. Some folks don't even get that. Isn't this National Cancer Awareness month? Yes, there are problems. But blaming management is short sided. You have not walked a mile in their shoes. You have no idea. You don't. You know a lot less then you think you do, at least about this management team. You want to get out, then get out. And then go away. I'm staying. More. I'm adding shares. If you can't add, then hold. And do it with some inner strength. Anyone who follows what I write knows that I write about potential and nothing has changed in the light of yesterday's news or today's news regarding MannKind, Technosphere, or Afrezza. In reality, we may never have ever had more than a year or two without financing issues with which to contend in the multi years I have been invested here. Al Mann will NOT allow MannKind to sink for want of capital to see the company through this difficult time, not with all that Al has already invested in ten years of development and a billion dollars of his own money. And, not with another billion in his portfolio. MannKind will be successful. Afrezza will be successful. Stop your sniveling. You've been given two victories this week. Sanofi reaffirmed and MannKind refinanced. Respect. Rob, thanks for this, easily one of the best posts in the wake of last nights call.
|
|
|
Post by lsl428 on Nov 10, 2015 8:52:09 GMT -5
Has anyone ever heard a CEO on a conference call plead for other companies to partner with them? That was a first for me and it really was awkward listening to Hakan do that. I have been thinking about that exact same thing....Just rookie like .....reaffirms the credibility of this management team.......strange
|
|
|
Post by mindovermatter on Nov 10, 2015 9:15:50 GMT -5
Ok, folks. This is what it comes down to and it's not like we should fein surprise at where the company is today. Anyone following our story and doing reasonable due diligence should know that the company needs to raise capital. It's not rocket science. The news has been out there for at least two financial quarters. It's time to man up now. Blame is for losers. Winners work harder. It's easy to complain when times are difficult. I'm adding to my position. I like the odds. I like the potential return on this $2+ stock. We have another year, for sure. And, after that, who knows. But that's what you get in life. Some folks don't even get that. Isn't this National Cancer Awareness month? Yes, there are problems. But blaming management is short sided. You have not walked a mile in their shoes. You have no idea. You don't. You know a lot less then you think you do, at least about this management team. You want to get out, then get out. And then go away. I'm staying. More. I'm adding shares. If you can't add, then hold. And do it with some inner strength. Anyone who follows what I write knows that I write about potential and nothing has changed in the light of yesterday's news or today's news regarding MannKind, Technosphere, or Afrezza. In reality, we may never have ever had more than a year or two without financing issues with which to contend in the multi years I have been invested here. Al Mann will NOT allow MannKind to sink for want of capital to see the company through this difficult time, not with all that Al has already invested in ten years of development and a billion dollars of his own money. And, not with another billion in his portfolio. MannKind will be successful. Afrezza will be successful. Stop your sniveling. You've been given two victories this week. Sanofi reaffirmed and MannKind refinanced. Respect. Rob, What are your thoughts when Hakan said this: "I have made it clear that I'm open to any creative approach that will give us as many of these programs as possibly funded, and get our technology into the hands of healthcare providers and their patients. So to the participants listening to this call, who have an interest in sharing the risk and the rewards of our product development effort or who have a formulation or drug delivery challenge that our technology may address, I would say this, let's talk. My ambition is to have a robust portfolio of product candidates in the pipeline by this time next year." I thought it was quite odd as I have never heard a CEO during a quarterly conference call give a sales pitch.
|
|
|
Post by silentknight on Nov 10, 2015 10:01:15 GMT -5
Well said, Denise...and I'm considering following your lead and trying to ignore the not-so-soft basher in the white coat.Can't zoom & can't tell; is that a sheepskin coat? I don't consider it "not-so-soft" bashing at all. He put forward his opinion, founded by his own experiences and uses what I believe to be logical conclusions based on what we've seen thus far. If putting forward the brutal reality of the current state of affairs is considered bashing, then people on this forum need to toughen up. The blind optimism that exists with some members here in the belief that everything is going to be ok and that changes aren't necessary to realize shareholder value and success for MNKD is laughable. Perhaps the company and SNY are working for those changes. I sincerely hope they are and I'm prepared to hold to give them time to realize them. I'm leveraged as heavily into MNKD as I am comfortable being, especially now based on my determinations of risk associated with MNKD after yesterday's 10-Q and conference call. Stevil's points are valid about most of what he's said. I appreciate everyone's opinion here, which is why I read. In the end, I believe we all want to see MNKD succeed, but I share Stevil's frustration as I am in a similar position with my MNKD holdings and believe we could, and should, be in a better position than we are now. Holding a company accountable for the proper stewardship of an investment is not bashing. Anyone who can't see the difference between the two likely lacks the intestinal fortitude necessary for financial investment.
|
|
|
Post by mnholdem on Nov 10, 2015 10:17:07 GMT -5
Has anyone ever heard a CEO on a conference call plead for other companies to partner with them? That was a first for me and it really was awkward listening to Hakan do that. I have been thinking about that exact same thing....Just rookie like .....reaffirms the credibility of this management team.......strange Plead? How do you get that interpretation from Hakan's comment:
"As I mentioned last quarter, we were pleased to welcome the new Chief Medical Officer leading the development team. And in the last couple of months, our development group has been very busy moving ahead with the formulation work on the pulmonary hypertension program, as well as lining up a dozen more product candidates with commercial potential. And there is no way we can fund all of this potential activity, so we have also initiated discussions with several firms that could participate in product development as strategic or financial partners. "I have made it clear that I'm open to any creative approach that will give us as many of these programs as possibly funded, and get our technology into the hands of healthcare providers and their patients. So to the participants listening to this call, who have an interest in sharing the risk and the rewards of our product development effort or who have a formulation or drug delivery challenge that our technology may address, I would say this, let's talk. My ambition is to have a robust portfolio of product candidates in the pipeline by this time next year."
---
It amazes me how the same shareholders who complain that Hakan is not using his leadership role, to promote MannKind, then turn around and criticize when he does. "...let's talk" is an invitation, not a plea. Hakan did exactly the right thing in promoting TS potential, and I hope that Hakan will soon start bringing Dr. Urbanski to speak at these conferences.
---
Finally - and the silence speaks VOLUMES here - where is mention of the pain med? I'm very confident at this point that we have a partner for a TS pain API and Hakan is restrained from even mentioning it by a confidentiality agreement. The pain pipeline is too big for Hakan to have ignored it like this. I'm speculating about a new partner, of course, but I'm going to put my money on it and start loading up. What did Hakan say about this? Here's his response to Jay Olson:
Jay Olson "Okay. And then, just on the pipeline, I appreciate the color there on the progress; can you tell us how close you are to moving any of your pipeline assets into the clinic, and when is the soonest that MannKind could sign a partnership or licensing deal to monetize some of those pipeline assets?"
Hakan Edstrom
"Well, in regards to -- I would say they are certainly month away from going into a clinic. I mean, they are in the formulation stage right now, particularly on the pulmonary hypertension. In regards to entering into other development partnership or financial partnership, the only thing I can say that, that actioned [ph] over the last week, we've had discussions with potential partners. However, there are still negotiations to be had. So I would say -- I would hope that we could possibly announce something before the end of the year -- oh, sorry, within the next quarter, but that's as specific as I can be at this point in time."
---
'nuff said.
|
|
|
Post by bradleysbest on Nov 10, 2015 10:21:52 GMT -5
Why is Al so silent? I would have thought he would be on a tour of the country promoting Afrezza's FDA approval & how big of an impact this will have on the diabetic community. Aside from the obvious (long investors) the losers will be the millions of diabetics who will continue to suffer. Sad state of affairs for a revolutionary product!
|
|
|
Post by mindovermatter on Nov 10, 2015 10:24:52 GMT -5
Why is Al so silent? I would have thought he would be on a tour of the country promoting Afrezza's FDA approval & how big of an impact this will have on the diabetic community. Aside from the obvious (long investors) the losers will be the millions of diabetics who will continue to suffer. Sad state of affairs for a revolutionary product! I don't believe Al is in good health and is limiting his travels.
|
|
|
Post by mindovermatter on Nov 10, 2015 10:29:58 GMT -5
I have been thinking about that exact same thing....Just rookie like .....reaffirms the credibility of this management team.......strange Plead? How do you get that interpretation from Hakan's comment:
"As I mentioned last quarter, we were pleased to welcome the new Chief Medical Officer leading the development team. And in the last couple of months, our development group has been very busy moving ahead with the formulation work on the pulmonary hypertension program, as well as lining up a dozen more product candidates with commercial potential. And there is no way we can fund all of this potential activity, so we have also initiated discussions with several firms that could participate in product development as strategic or financial partners. "I have made it clear that I'm open to any creative approach that will give us as many of these programs as possibly funded, and get our technology into the hands of healthcare providers and their patients. So to the participants listening to this call, who have an interest in sharing the risk and the rewards of our product development effort or who have a formulation or drug delivery challenge that our technology may address, I would say this, let's talk. My ambition is to have a robust portfolio of product candidates in the pipeline by this time next year."
---
It amazes me how the same shareholders who complain that Hakan is not using his leadership role, to promote MannKind, then turn around and criticize when he does.
"...let's talk" is an invitation. Hakan did exactly the right thing, and I hope that Hakan will soon start bringing Dr. Urbanski to speak at these conferences.
---
Finally, the silence speaks VOLUMES here... where is mention of the pain med? I'm very confident at this point that we have a partner for a TS pain API and Hakan is restrained from even mentioning it by a confidentiality agreement. The pain pipeline is too big for Hakan to have ignored it like this. I'm speculating about a new partner, of course, but I'm going to put my money on it and start loading up. What did Hakan say about this? Here's his response to Jay Olson:
Jay Olson "Okay. And then, just on the pipeline, I appreciate the color there on the progress; can you tell us how close you are to moving any of your pipeline assets into the clinic, and when is the soonest that MannKind could sign a partnership or licensing deal to monetize some of those pipeline assets?"
Hakan Edstrom
"Well, in regards to -- I would say they are certainly month away from going into a clinic. I mean, they are in the formulation stage right now, particularly on the pulmonary hypertension. In regards to entering into other development partnership or financial partnership, the only thing I can say that, that actioned [ph] over the last week, we've had discussions with potential partners. However, there are still negotiations to be had. So I would say -- I would hope that we could possibly announce something before the end of the year -- oh, sorry, within the next quarter, but that's as specific as I can be at this point in time."
---
'nuff said.
Two things. 1) Did Mannkind not mention that they'd have one TS candidate announce by the EOY about 6 months ago or am I mistaken on ? 2) While I haven't personally said anything about Hakan and his ability to promote, you don't find it quite odd he did so during a quarterly conference call? And that didn't struck you as odd if not almost borderline desperate? I have heard plenty of calls and never have I heard a CEO do that. I just don't think that was the place to do so. Hopefully he'll get some calls.
|
|
|
Post by bradleysbest on Nov 10, 2015 10:38:59 GMT -5
It was said by Matt in June at the Piper Jaffray conference in NYC.....
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 10, 2015 10:52:10 GMT -5
Has anyone ever heard a CEO on a conference call plead for other companies to partner with them? That was a first for me and it really was awkward listening to Hakan do that. that was so extreme from my point of view that I almost fell out of my chair in disbelief that he actually said that. No experienced and seasoned ceo would put words like that together on a quarterly CC and it was a mistake to leave that flavor in peoples mouth. Any ceo that is successfully selling their wares doesn't need to ask for phone calls during a quarterly CC. It runs counter to the idea that they are about to sign a deal in the next few months or even close to signing a deal. That may not be true, but the way he handled it makes it seem less likely.
|
|
|
Post by hankscorpio7 on Nov 10, 2015 10:57:01 GMT -5
Has anyone ever heard a CEO on a conference call plead for other companies to partner with them? That was a first for me and it really was awkward listening to Hakan do that. that was so extreme from my point of view that I almost fell out of my chair in disbelief that he actually said that. No experienced and seasoned ceo would put words like that together on a quarterly CC and it was a mistake to leave that flavor in peoples mouth. Any ceo that is successfully selling their wares doesn't need to ask for phone calls during a quarterly CC. It runs counter to the idea that they are about to sign a deal in the next few months or even close to signing a deal. That may not be true, but the way he handled it makes it seem less likely. I thought he said this as well last time- or something similar. Not sure who he thinks will be listening to a MNKD cc. Maybe it is his signature move.
|
|
|
Post by mindovermatter on Nov 10, 2015 10:58:50 GMT -5
Has anyone ever heard a CEO on a conference call plead for other companies to partner with them? That was a first for me and it really was awkward listening to Hakan do that. that was so extreme from my point of view that I almost fell out of my chair in disbelief that he actually said that. No experienced and seasoned ceo would put words like that together on a quarterly CC and it was a mistake to leave that flavor in peoples mouth. Any ceo that is successfully selling their wares doesn't need to ask for phone calls during a quarterly CC. It runs counter to the idea that they are about to sign a deal in the next few months or even close to signing a deal. That may not be true, but the way he handled it makes it seem less likely. I said to myself when I heard him make the pitch, "He just didn't do that, did he?" Then I said, "tomorrow is going be a blood bath as that is a desperate move made by a desperate CEO." And here we are today with MNKD down 11% so far. The only other thing is thank god SNY is doing the marketing and selling because at this point I have absolutely no faith in the management team.
|
|
|
Post by suebeeee1 on Nov 10, 2015 10:59:43 GMT -5
Regardless of whether or not a technospere deal is pending, it is probably now time for the BOD to consider a new CEO. We need someone with the experience to get us through rough waters without putting his foot in his mouth. He may have been exasperated at the pounding of questions he received, but there was no excuse for his comment. I was stunned, as apparently others were. Maybe he is the best CEO since sliced bread. We might need peanut butter right now though.
|
|
|
Post by robsacher on Nov 10, 2015 12:11:34 GMT -5
Ok, folks. This is what it comes down to and it's not like we should fein surprise at where the company is today. Anyone following our story and doing reasonable due diligence should know that the company needs to raise capital. It's not rocket science. The news has been out there for at least two financial quarters. It's time to man up now. Blame is for losers. Winners work harder. It's easy to complain when times are difficult. I'm adding to my position. I like the odds. I like the potential return on this $2+ stock. We have another year, for sure. And, after that, who knows. But that's what you get in life. Some folks don't even get that. Isn't this National Cancer Awareness month? Yes, there are problems. But blaming management is short sided. You have not walked a mile in their shoes. You have no idea. You don't. You know a lot less then you think you do, at least about this management team. You want to get out, then get out. And then go away. I'm staying. More. I'm adding shares. If you can't add, then hold. And do it with some inner strength. Anyone who follows what I write knows that I write about potential and nothing has changed in the light of yesterday's news or today's news regarding MannKind, Technosphere, or Afrezza. In reality, we may never have ever had more than a year or two without financing issues with which to contend in the multi years I have been invested here. Al Mann will NOT allow MannKind to sink for want of capital to see the company through this difficult time, not with all that Al has already invested in ten years of development and a billion dollars of his own money. And, not with another billion in his portfolio. MannKind will be successful. Afrezza will be successful. Stop your sniveling. You've been given two victories this week. Sanofi reaffirmed and MannKind refinanced. Respect. Rob, What are your thoughts when Hakan said this: "I have made it clear that I'm open to any creative approach that will give us as many of these programs as possibly funded, and get our technology into the hands of healthcare providers and their patients. So to the participants listening to this call, who have an interest in sharing the risk and the rewards of our product development effort or who have a formulation or drug delivery challenge that our technology may address, I would say this, let's talk. My ambition is to have a robust portfolio of product candidates in the pipeline by this time next year." I thought it was quite odd as I have never heard a CEO during a quarterly conference call give a sales pitch. I have no problem with the company CEO looking for business. You're reading way more into this than you need to be. I'm sure that the company already has a number of possible drug partnerships in play. Hakan was just trying to show that Technosphere can be used with any number of additional possibilities.
|
|
|
Post by lakers on Nov 10, 2015 12:34:49 GMT -5
Remember Hakan said that in a prepared statement. Don't think for a moment that Al didn't review and approve that. Hakan may have directed at GS, JPM, soliciting and possibly entertaining the idea of retaining them as advisors to explore strategic options. He knew who important listeners were.
Teva, GSK, Sny might have listened in too.
As advisors, GS would stop the attack. BoD meeting in Nov 2nd half 2015 will decide on TS partnership. LA Times 11/8/15 cited Hakan on Pain Med which already finished animal trial. Interestingly, Hakan didn't mention that in CC at all thereby showing his hand.
IMHO, MNKD tried to time TS deal w/ fund raising, Notes settlement. Apparently, the potential partners saw that and drug out the negotiations trying to wring out concessions.
With TASE deal done, MNKD will negotiate w/ strength. Even AF said it was a brilliant move.
IMHO, Sny is licking its chop. Nothing can stop them buying in 5%, 22M shares at $2.50/sh OTC. Xmas comes early for them thanks to Al's intransigence.
|
|